P02976 (SPA_STAA8) Staphylococcus aureus (strain NCTC 8325 / PS 47)
Immunoglobulin G-binding protein A UniProtKBInterProSTRINGInteractive Modelling
516 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
28 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Coevolved affibody-Z domain pair LL1.c4 |
Heteromer | 1×GOL; | ||||
| Assess | ||||||
| An affibody in complex with a target protein: structure and coupled folding |
Heteromer | |||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL1.c6 |
Heteromer | 1×MLI; | ||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL1.c1 |
Heteromer | 1×SO4; 2×MLI; | ||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL2.c22 |
Heteromer | 1×GOL; | ||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL2.c3 |
Heteromer | 1×GOL; 1×SO4; | ||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL1.c5 |
Heteromer | |||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL1.c2 |
Heteromer | |||||
| Assess | ||||||
| Application of anti-helix antibodies in protein structure determination (8496-3LRH) |
Heteromer | |||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL2.c1 |
Heteromer | 1×GOL; | ||||
| Assess | ||||||
| IgG Fc bound to 3 helix of the B-domain from Protein A |
Heteromer P01857; | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL2.c7 |
Heteromer | 1×MLI; | ||||
| Assess | ||||||
| Coevolved affibody-Z domain pair LL2.c17 |
Heteromer | |||||
| Assess | ||||||
| Application of anti-helix antibodies in protein structure determination (8188cys-3LRHcys) |
Heteromer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO-PEG3-MEDITOPE |
Heteromer Q51918; | 1×MRY; | ||||
| Assess | ||||||
| STRUCTURE OF MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT |
Heteromer Q51918; | 1×MRY; | ||||
| Assess | ||||||
| Application of anti-helix antibodies in protein structure determination (8189-3LRH) |
Heteromer | |||||
| Assess | ||||||
| MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (Ac) CQFDA(PH)2STRRLRCGGSK |
Heteromer Q51918; | 1×MRY; | ||||
| Assess | ||||||
| Trastuzumab Fab v3 |
Heteromer P01834; Q51918; S6B291; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO-MEDITOPE |
Heteromer Q51918; | 1×MRY; | ||||
| Assess | ||||||
| Trastuzumab Fab v3 with 5-diphenyl meditope variant |
Heteromer P01834; Q51918; Q6GMX6; | |||||
| Assess | ||||||
| Application of anti-helix antibodies in protein structure determination (8188-3LRH) |
Heteromer | |||||
| Assess | ||||||
| Trastuzumab Fab v3 in complex with 5-phenyl meditope variant |
Heteromer P01834; Q51918; Q6GMX6; | |||||
| Assess | ||||||
| Trastuzumab Fab v3 in complex with CQFDLSTRRLKC |
Heteromer P01834; Q51918; S6B291; | |||||
| Assess | ||||||
| Structure of S. aureus protein A bound to a human IgM Fab |
Heteromer | |||||
| Assess | ||||||
| Application of anti-helix antibodies in protein structure determination (9014-1P4B) |
Heteromer | |||||
| Assess | ||||||
| Application of anti-helix antibodies in protein structure determination (8420-3MNZ) |
Heteromer | |||||
| Assess | ||||||
| NMR solution structure of staphylococcal protein A, C domain | monomer | |||||
| Assess | ||||||
7 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4npf.2.A | monomer | 0.74 | 93.97 | |||
| Assess | ||||||
| 4npf.2.A | monomer | 0.73 | 74.34 | |||
| Assess | ||||||
| 4npf.2.A | monomer | 0.69 | 93.10 | |||
| Assess | ||||||
| 5h7c.1.A | monomer | 0.69 | 59.14 | |||
| Assess | ||||||
| 5h7b.1.A | monomer | 0.66 | 83.26 | |||
| Assess | ||||||
| 5xby.1.B | monomer | 0.64 | 61.80 | |||
| Assess | ||||||
| 5xby.2.B | monomer | 0.62 | 67.42 | |||
| Assess | ||||||